Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius C Enssle

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of Hematology|May 15, 2025
Immune responses after one versus two Influenza A/B vaccinations in patients with multiple myelomaJulius C Enssle, Tonio Brinkschmidt, Ralf Dürrwald, et al.
Briefings in Bioinformatics|June 29, 2026
Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneitySareh Amerifar, Andreas Kopf, Steffen Sass, et al.
Annals of Hematology|August 8, 2023
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AMLAnjali Cremer, Julius C Enssle, Saskia Pfaff, et al.
Oncoimmunology|May 14, 2025
Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapyStefan Enssle, Anna Sax, Peter May, et al.
Infection|May 28, 2026
vanA-consistent phenotype vancomycin-resistant enterococcal colonization is associated with inferior overall survival in acute myeloid leukemia patients undergoing intensive chemotherapy: a single-center retrospective studySebastian Wolf, Nico Zeltner, Nele Henze, et al.
Infection|April 2, 2025
Epidemiology and outcomes of Candida spp. bloodstream infections in cancer patients: a comparative retrospective study from a German tertiary cancer centerSebastian Wolf, Sarah Weber, Aaron Janetta, et al.
Cancer Cell|May 19, 2022
Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myelomaJulius C Enssle, Julia Campe, Sarah Büchel, et al.
Cancer Cell|January 16, 2026
Axes of biological variation in diffuse large B cell lymphomaBoya Wang, George Wright, Julius C Enssle, et al.
Leukemia|December 4, 2023
Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patientsJulius C Enssle, Julia Campe, Alina Moter, et al.
Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of Hematology|May 15, 2025
Immune responses after one versus two Influenza A/B vaccinations in patients with multiple myelomaJulius C Enssle, Tonio Brinkschmidt, Ralf Dürrwald, et al.
Briefings in Bioinformatics|June 29, 2026
Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneitySareh Amerifar, Andreas Kopf, Steffen Sass, et al.
Annals of Hematology|August 8, 2023
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AMLAnjali Cremer, Julius C Enssle, Saskia Pfaff, et al.
Oncoimmunology|May 14, 2025
Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapyStefan Enssle, Anna Sax, Peter May, et al.
Infection|May 28, 2026
vanA-consistent phenotype vancomycin-resistant enterococcal colonization is associated with inferior overall survival in acute myeloid leukemia patients undergoing intensive chemotherapy: a single-center retrospective studySebastian Wolf, Nico Zeltner, Nele Henze, et al.
Infection|April 2, 2025
Epidemiology and outcomes of Candida spp. bloodstream infections in cancer patients: a comparative retrospective study from a German tertiary cancer centerSebastian Wolf, Sarah Weber, Aaron Janetta, et al.
Cancer Cell|May 19, 2022
Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myelomaJulius C Enssle, Julia Campe, Sarah Büchel, et al.
Cancer Cell|January 16, 2026
Axes of biological variation in diffuse large B cell lymphomaBoya Wang, George Wright, Julius C Enssle, et al.
Leukemia|December 4, 2023
Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patientsJulius C Enssle, Julia Campe, Alina Moter, et al.
Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.
Pageof 2